[1]滕汝枫,刘攀,孙士晶,等.针刺调控血管内皮生长因子C治疗乳腺癌淋巴水肿机制研究进展[J].陕西中医,2025,46(8):1150-封3.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.029]
　TENG Rufeng,LIU Pan,SUN Shijing,et al.Mechanism of acupuncture regulating vascular endothelial growth factor C in the treatment of lymphedema of breast cancer[J].,2025,46(8):1150-封3.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.029]
点击复制

针刺调控血管内皮生长因子C治疗乳腺癌淋巴水肿机制研究进展

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年8期
页码:
1150-封3
栏目:
综 述
出版日期:
2025-08-05

文章信息/Info

Title:
Mechanism of acupuncture regulating vascular endothelial growth factor C in the treatment of lymphedema of breast cancer
作者:
滕汝枫1; 刘攀2; 孙士晶3; 王敏3; 尹兴玲3
（1.北京中医药大学东方医院，北京 100078；2.枣庄市胸科医院，山东 枣庄 277000；3.北京中医药大学东方医院枣庄医院，山东 枣庄 277000）
Author(s):
TENG Rufeng1; LIU Pan2; SUN Shijing3; WANG Min3; YIN Xingling3
(1.Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China；2.Zaozhuang Chest Hospital,Zaozhuang 277000，China；3.Beijing University of Chinese Medicine Dongfang Hospital Zaozhuang Hospital,Zaozhuang 277000，China)
关键词:
乳腺癌淋巴水肿; 针刺; 血管内皮生长因子C; 淋巴管新生; 机制研究
Keywords:
Breast cancer-related lymphedema; Acupuncture; Vascular endothelial growth factor C; Lymphangiogenesis; Mechanism research
分类号:
R 737.9
DOI:
DOI:10.3969/j.issn.1000-7369.2025.08.029
文献标志码:
A
摘要:
乳腺癌淋巴水肿是乳腺癌术后常见的并发症，严重影响患者生活质量。血管内皮生长因子C对淋巴管的内皮细胞具有重要生物学作用，与乳腺癌淋巴水肿的发生密切相关，因此调节血管内皮生长因子C水平对于延缓病情、缓解症状具有重要意义。针刺可通过调节血管内皮生长因子C促进淋巴管新生、改善血管通透性、抑制炎症来治疗乳腺癌淋巴水肿。基于血管内皮生长因子C角度对针刺治疗乳腺癌淋巴水肿的机制研究进行综述。
Abstract:
Breast cancer-related lymphedema (BCRL)is a common complication after breast cancer surgery,which seriously affects the quality of life of patients.Vascular endothelial growth factor C (VEGF-C) plays an important biological role in lymphatic endothelial cells and is closely related to the occurrence of breast cancer-related lymphedema.Therefore,regulating the level of VEGF-C is of great significance for delaying the disease progression and alleviating symptoms.Acupuncture can treat breast cancer-related lymphedema by regulating VEGF-C to promote lymphangiogenesis,improve vascular permeability,and inhibit inflammation.This article reviews the research progress on the mechanism of acupuncture in treating breast cancer-related lymphedema from the perspective of VEGF-C.

参考文献/References:

[1]MARCHICA P,D’ARPA S,MAGNO S,et al.Integrated treatment of breast cancer-related lymphedema:A descriptive review of the state of the art[J].Anticancer Res,2021,41(7):3233-3246.
[2]BYUN H K,CHANG J S,IM S H,et al.Risk of lymphedema following contemporary treatment for breast cancer:An analysis of 7617 consecutive patients from a multidisciplinary perspective[J].Ann Surg,2021,274(1):170-178.
[3]MEHRARA B J,PARK H J,KATARU R P,et al.Pilot study of anti-Th2 immunotherapy for the treatment of breast cancer-related upper extremity lymphedema[J].Biology (Basel),2021,10(9):934.
[4]BERNAS M,THIADENS S,STEWART P,et al.Secondary lymphedema from cancer therapy[J].Clin Exp Metastasis,2022,39(1):239-247.
[5]EATON L H,NARKTHONG N,HULETT J M.Psychosocial issues associated with breast cancer-related lymphedema:A literature review[J].Curr Breast Cancer Rep,2020,12(4):216-224.
[6]DE VRIEZE T,NEVELSTEEN I,THOMIS S,et al.What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema?A systematic review[J].Support Care Cancer,2020,28(2):439-449.
[7]DE SIRE A,LOSCO L,LIPPI L,et al.Surgical treatment and rehabilitation strategies for upper and lower extremity lymphedema:A comprehensive review[J].Medicina (Kaunas),2022,58(7):954.
[8]BAO T,IRIS Z W,VERTOSICK E A,et al.Acupuncture for breast cancer-related lymphedema:A randomized controlled trial[J].Breast Cancer Res Treat,2018,170(1):77-87.
[9]杨蕊,张艺萱,张春畅,等.针灸治疗乳腺癌淋巴水肿的系统评价和Meta分析[J].针刺研究,2024,49(7):715-725.
[10]POTENTE M,MAKINEN T.Vascular heterogeneity and specialization in development and disease[J].Nat Rev Mol Cell Biol,2017,18(8):477-494.
[11]王华寿,卢陈嘉,黄俊文,等.肺癌组织环指蛋白181、转移相关基因1、血管内皮生长因子C表达及与患者临床病理特征和预后相关性分析[J].陕西医学杂志,2023,52(1):110-113.
[12]PATEL S A,NILSSON M B,LE X,et al.Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy[J].Clin Cancer Res,2023,29(1):30-39.
[13]HOSSAIN L,GOMES K P,YANG X,et al.Vascular endothelial growth factor C (VEGF-C) sensitizes lymphatic endothelial cells to oxidative-stress-induced apoptosis through DNA damage and mitochondrial dysfunction:Implications for lymphedema[J].Int J Mol Sci,2024,25(14):7828.
[14]DUCOLI L,DETMAR M.Beyond PROX1:Transcriptional,epigenetic,and noncoding RNA regulation of lymphatic identity and function[J].Dev Cell,2021,56(4):406-426.
[15]ZHOU H,WANG M,HOU C,et al.Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema[J].Jpn J Clin Oncol,2011,41(7):841-846.
[16]LEE S H,JEONG D,HAN Y S,et al.Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis[J].Ann Surg Treat Res,2015,89(1):1-8.
[17]MELINCOVICI C S,BOSCA A B,SUSMAN S,et al.Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467.
[18]VAN HOVE A H,BENOIT D S.Depot-based delivery systems for pro-angiogenic peptides:A review[J].Front Bioeng Biotechnol,2015,3:102.
[19]KIM I S,YANG W S,KIM C H.Physiological properties,functions,and trends in the matrix metalloproteinase inhibitors in inflammation-mediated human diseases[J].Curr Med Chem,2023,30(18):2075-2112.
[20]WAKASUGI R,SUZUKI K,KANEKO-KAWANO T.Molecular mechanisms regulating vascular endothelial permeability[J].Int J Mol Sci,2024,25(12):6415.
[21]JIANG X,NICOLLS M R,TIAN W,et al.Lymphatic dysfunction,leukotrienes,and lymphedema[J].Annu Rev Physiol,2018,80:49-70.
[22]ZHOU C,SUN T,DONG Z,et al.The interplay between lymphatic vessels and macrophages in inflammation response[J].FASEB J,2024,38(16):e23879.
[23]KATARU R P,BAIK J E,PARK H J,et al.Regulation of immune function by the lymphatic system in lymphedema[J].Front Immunol,2019,10:470.
[24]HWANG I,KIM J W,YLAYA K,et al.Tumor-associated macrophage,angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients[J].J Transl Med,2020,18(1):443.
[25]GUZIK T J,NOSALSKI R,MAFFIA P,et al.Immune and inflammatory mechanisms in hypertension[J].Nat Rev Cardiol,2024,21(6):396-416.
[26]YANEZ D C,LAU C I,PAPAIOANNOU E,et al.The pioneer transcription factor Foxa2 modulates T helper differentiation to reduce mouse allergic airway disease[J].Front Immunol,2022,13:890781.
[27]REHAL S,KATARU R P,HESPE G E,et al.Regulation of lymphatic function and injury by nitrosative stress in obese mice[J].Mol Metab,2020,42:101081.
[28]DENG C,WU Z,CAI Z,et al.Conservative medical intervention as a complement to CDT for BCRL therapy:A systematic review and meta-analysis of randomized controlled trials[J].Front Oncol,2024,14:1361128.
[29]高华嵩,周佳晓,石磊,等.针刺预处理对卒中后血管性认知障碍大鼠血管新生的影响[J].世界中西医结合杂志,2024,19(2):281-287.
[30]ZUO H Y,WU S B,WU X,et al.Effect of electroacupuncture on myocardial inflammatory injury and apoptosis in mice with acute myocardial ischemia based on VEGF-C/VEGFR-3 pathway[J].Zhongguo Zhen Jiu,2022,42(11):1269-1277.
[31]MA S X.Nitric oxide signaling molecules in acupoints:Toward mechanisms of acupuncture[J].Chin J Integr Med,2017,23(11):812-815.
[32]RIDNER S H,DIETRICH M S,SONIS S T,et al.Biomarkers associated with lymphedema and fibrosis in patients with cancer of the head and neck[J].Lymphat Res Biol,2018,16(6):516-524.
[33]ZHANG Q,ZHOU M,HUO M,et al.Mechanisms of acupuncture-electroacupuncture on inflammatory pain[J].Mol Pain,2023,19:814404162.
[34]李倩.“醒脑开窍”针刺法对脑中风后遗症患者血清炎症因子及血管内皮功能的影响[J].陕西中医,2022,43(1):114-117.
[35]刘顺畅,姜春宏,贺丽丽,等.基于VEGF-C/VEGFR-3信号通路电针预处理促淋巴管再生修复淋巴水肿的作用机制研究[J].时珍国医国药,2024,35(5):1272-1276.
[36]蔡丽珍,白瑞娜,张路,等.基于“痰夹瘀血”理论探讨乳腺癌相关淋巴水肿因机治疗[J].陕西中医,2023,44(10):1420-1423.
[37]林婕,张海添,胡军.中医外治法治疗乳腺癌相关淋巴水肿研究进展[J].中国中医药现代远程教育,2024,22(14):146-148.

相似文献/References:

[1]应洁秋,徐雪荔.针刺联合康复训练治疗缺血性中风早期肩手综合征临床研究[J].陕西中医,2019,(1):128.
　YING Qieqiu,XU Xueli..Effect of acupuncture plus rehabilitation training on shoulderhand syndrome due to early ischemic stroke[J].,2019,(8):128.
[2]张连生,王月田,张志洋.针刺、西替利嗪联合曲安奈德喷雾剂治疗变应性鼻炎疗效 及对患者RQLQ评分、slgE、血清炎症因子的影响*[J].陕西中医,2019,(4):534.
[3]杨海峰,彭 辉,刘 琰.针刺联合康复治疗对急性期缺血性脑卒中患者肢体运动功能障碍的影响*[J].陕西中医,2019,(6):708.
[4]马宁宁,邓彩艳,姚爱梅,等.针刺结合头孢硫脒治疗小儿急性扁桃体炎临床研究*[J].陕西中医,2019,(7):948.
　MA Ningning,DENG Caiyan,YAO Aimei,et al.Clinical efficacy of acupuncture combined with cefathiamidine in the treatment of infantile acute tonsillitis[J].,2019,(8):948.
[5]许 斌,史栋梁,王子华.痹祺胶囊联合针刺治疗神经根型颈椎病疗效研究*[J].陕西中医,2019,(9):1222.
　XU Bin,SHI Dongliang,WANG Zihua..Clinical analysis of Biqi capsule combined with acupuncture in treating cervical spondylotic radiculopathy[J].,2019,(8):1222.
[6]钟如春,刘 霞,卢 欣.理气和胃调神法针刺治疗中风后呃逆疗效研究[J].陕西中医,2019,(9):1288.
　ZHONG Ruchun,LIU Xia,LU Xin..Clinical observation of treatment with Liqi Hewei Tiaoshen acupuncture on poststroke hiccup[J].,2019,(8):1288.
[7]王会丽,刘瑞芳,马爱琴.针刺联合弧刃针疗法治疗肩周炎疗效及对患者肩关节功能、活动度、肌力的影响*[J].陕西中医,2019,(10):1457.
[8]訾 璐,胡小军△,王 玉,等.针刺中脘穴联合自拟茶方对2型糖尿病患者血糖水平的影响*[J].陕西中医,2019,(10):1460.
　ZI Lu,HU Xiaojun,WANG Yu,et al.Effect of zhong wan acupuncture combined with selfdesigned tea prescription on blood glucose level in patients with type 2 diabetes mellitus[J].,2019,(8):1460.
[9]王 雷,郭运岭,王 壮,等.“柔筋调脊”针法治疗腰椎间盘突出症所致慢性腰腿痛疗效研究*[J].陕西中医,2019,(10):1464.
　WANG Lei,GUO Yunling,WANG Zhuang,et al.Observation of the clinical effects on chronic lumbar and leg pain caused by lumbar disc herniation treated with soft muscle and adjust spine acupuncture[J].,2019,(8):1464.
[10]乔峰,强文娟,高东,等.葛根芩连汤配合针刺治疗溃疡性结肠炎活动期大肠湿热证临床研究*[J].陕西中医,2019,(11):1516.
　QIAO Feng,QIANG Wenjuan,GAO Dong,et al.Gegen Qinlian decoction combined with acupuncture for ulcerative colitis with large intestine dampheat syndrome at active stage[J].,2019,(8):1516.

备注/Memo

备注/Memo:
国家自然科学基金资助面上项目（81874473）；国家中医药管理局重点专科专项课题（040203001019）；山东省中医药重点学科项目[鲁卫中医药科教字（2022）4号]；北京中医药大学研究生自主科研课题（90011461220382）
更新日期/Last Update: 2025-08-08